THY1 and scleroderma: CD90+ fibroblasts have been shown to be generated and replaced by a steady-state CD34+ network in scleroderma, and the findings suggested that most scars exhibit a CD90diffuse/CD34negative/minority pattern, and dual CD90+ /CD34+ fibroblasts were observed in 91% of scars.